AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2020
Nov 2, 2020
30718_dirs_2020-11-02_970be993-1021-4ad8-927b-74283ca919da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-10-29
Reporting Person: VESSEY RUPERT (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-10-29 | Common Stock | A | 391.00 | $0.00 | Acquired | 1033.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-10-29 | Stock Option (Right to Buy) | $255.69 | A | 1507.00 | Acquired | 2030-10-29 | Common Stock (1507.00) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to buy) | $209.26 | 2029-10-25 | Common Stock (588.00) | 588.00 | Direct |
| Stock Option (Right to buy) | $201.64 | 2029-10-24 | Common Stock (2011.00) | 2011.00 | Direct |
Footnotes
F1: The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne's 2021 annual meeting of shareholders.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4